Nature GeneticsCancer BiologyPeer-reviewed journal article
TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancer
Elissa W.P. WongiD, Merve ŞahiniD, Rui YangiD, UkJin LeeiD, Dan LiiD, Yingqian Ada ZhaniD, Rohan MisraiD, Fanny V. Tomas, Nawaf AlomraniD, Alexander PolyzosiD, Cindy J. LeeiD, Tuan Trieu, Alexander Martinez‐FundichelyiD, Thomas WiesneriD, Andrew RosowicziD, Shuyuan ChengiD, Christina Liu, Morgan Lallo, Alexander Noor ShoushtariiD, Taha MerghoubiD, Pierre-Jacques HamardiD, Richard P. KocheiD, Ekta KhuranaiD, Effie ApostolouiD, Deyou ZhengiD, , Ping ChiiD
Abstract
Transposable elements (TEs) are abundant in the human genome, and they provide the sources for genetic and functional diversity. The regulation of TEs expression and their functional consequences in physiological conditions and cancer development remain to be fully elucidated. Previous studies suggested TEs are repressed by DNA methylation and chromatin modifications. The effect of 3D chromatin topology on TE regulation remains elusive. Here, by integrating transcriptome and 3D genome architecture studies, we showed that haploinsufficient loss of NIPBL selectively activates alternative promoters at the long terminal repeats (LTRs) of the TE subclasses. This activation occurs through the reorganization of topologically associating domain (TAD) hierarchical structures and recruitment of proximal enhancers. These observations indicate that TAD hierarchy restricts transcriptional activation of LTRs that already possess open chromatin features. In cancer, perturbation of the hierarchical chromatin topology can lead to co-option of LTRs as functional alternative promoters in a context-dependent manner and drive aberrant transcriptional activation of novel oncogenes and other divergent transcripts. These data uncovered a new layer of regulatory mechanism of TE expression beyond DNA and chromatin modification in human genome. They also posit the TAD hierarchy dysregulation as a novel mechanism for alternative promoter-mediated oncogene activation and transcriptional diversity in cancer, which may be exploited therapeutically.
- organism: human
- assay: bulk RNA-seq
- assay: Hi-C
- research focus: chromatin & epigenetic regulation
- research focus: cancer & tumor microenvironment
- research focus: gene regulatory network inference
- approach: experimental assay
- Citations
- 10
- FWCI
- 2.40
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transposable elements as tissue-specific enhancers in cancers of endodermal lineage
Konsta Karttunen, Divyesh Patel, … Biswajyoti Sahu·Nature CommunicationsPeer-reviewed·Sep 1, 2023
- Retroelement co-option disrupts the cancer transcriptional programme
Jane Ho Chun Loong, R. Houston Thompson, … George Kassiotis·Genome MedicinePeer-reviewed·May 7, 2025
- Single cell analysis reveals dynamics of transposable element transcription following epigenetic de-repression
David Brocks, Elad Chomsky, … Amos Tanay·bioRxiv·Jul 20, 2019
- Transposable elements generate regulatory novelty in a tissue-specific fashion
Marco Trizzino, Aurélie Kapusta, Christopher D. Brown·BMC GenomicsPeer-reviewed·Jun 18, 2018
- Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes
D. Patel, V. Tiusanen, … B. Sahu·bioRxiv·Jan 15, 2024
- H4K16ac activates transcription of transposable elements and contribute to their cis regulatory function
Debosree Pal, Manthan Patel, … Madapura M. Pradeepa·Nature Structural & Molecular BiologyPeer-reviewed·Jun 12, 2023